Medicines recallMHRA
Ramipril 2.5 mg Capsules recalled over a packaging defect
Crescent Pharma Limited is initiating a precautionary recall of one batch of Ramipril 2.5 mg Capsules following the identification of a potential packaging error at the manufacturing site.
Check your product
Only products that match these details are covered. Have your pack in front of you.
4 identifiers listed for this notice.
Ramipril 2.5 mg Capsules 28
- Batch codePrinted on the pack, often next to the date mark. It may start with L or LOT.
- GR155023
- Product licenceThe PL number on the carton.
- PL 20416/0295
- ExpiryOn the carton, blister or label.
- 08/2027
- First distributedOn the product, its label or its packaging.
- 16 Jan 2026
What to do now
A fault with the packaging or delivery device of Ramipril 2.5 mg Capsules has been found.
- Keep taking your medicine unless a healthcare professional tells you otherwise.
- Check the batch number and expiry date on your pack against the list on this page.
- If it matches, your pharmacist can swap it or arrange an alternative.
- Report suspected side effects to the MHRA Yellow Card scheme.
Why it matters. A faulty cap, seal, syringe or inhaler can mean a missed or wrong dose, or contamination of the product.
Symptoms and when to get help
Look out for
- a side effect you have not had before
- your condition not being controlled as well as usual
Get help urgently
- signs of a severe allergic reaction, such as swelling of the face or throat or difficulty breathing — call 999
- if you feel unwell and are worried, speak to a pharmacist, your GP or NHS 111
This is general information based on NHS public guidance, not medical advice. In an emergency call 999. For urgent advice use NHS 111 (NHS 24 on 111 in Scotland) or, in Northern Ireland, your GP or out-of-hours service.
Replacements and prescriptions
If your pack is affected, your pharmacy can usually exchange it for an unaffected batch or another suitable product. Prescription medicines are replaced through your pharmacy or prescriber; you do not need to buy a new supply yourself.
Many recalls are made at pharmacy or wholesaler level and do not require patients to act. The notice says which level applies.
From the official notice
Published by the Medicines and Healthcare products Regulatory Agency (EL(26)A/25). Quoted as issued.
Summary
Crescent Pharma Limited is initiating a precautionary recall of one batch of Ramipril 2.5 mg Capsules following the identification of a potential packaging error at the manufacturing site.
The risk
DMRC reference number DMRC - 39617807 Marketing Authorisation Holder
Advice for healthcare professionals
stop supplying the impacted batch of Ramipril 2.5mg Capsules (batch number GR155023) immediately. Quarantine all remaining stock and return it to your supplier using your approved process
Consideration of the following patient communication should be considered within 48 hours of the alert and actioned within 5 working days:
if batch/product traceability information is available, healthcare professionals involved in dispensing medicinal products should contact all patients who have been dispensed the impacted product and ask them to inspect the packs they have in their possession
if batch/product traceability information is not available, pharmacists should identify all patients dispensed this product between 16 Jan 2026 and 22 May 2026. Attempts should be made to contact patients who have been dispensed the impacted product within the last 28 days as a priority
any patients with impacted packs should be told to stop taking them immediately, return them to the pharmacy and contact their GP practice. Patients with non-impacted packs (majority of patients) should be informed they may continue to take the capsules from this batch
where patients are identified with a defective pack they should be told to contact their prescriber responsible for their care to discuss treatment review and if a new prescription is required for ongoing resupply
Ramipril is a standard anti-hypertensive used in the treatment of hypertension, kidney disease and heart failure. The key risk associated with this defect is unintentional overdosing, where patients prescribed Ramipril 2.5 mg capsules may receive 10 mg capsules. Signs and symptoms may include feeling lightheaded, fainting, fatigue, or altered kidney function and be more serious for at risk or vulnerable patients.
Healthcare professionals should be aware that only the Ramipril 2.5mg Capsules batch stated in this notification is impacted.
Some cartons of Ramipril 2.5mg Capsules, manufactured by Crescent Pharma Limited, may contain blister strips of Ramipril 10 mg Capsules and are being recalled at the pharmacy level as a precautionary measure.
If you were prescribed Ramipril 2.5 mg Capsules, and received a Crescent pack with batch number GR155023, please check the blister strips inside (the batch number and expiry date information can be found on outer carton, see the images in Annex 1).
if the carton contains blister strips that are labelled as Ramipril 2.5 mg Capsules, you do not need to take further action and may continue to take the capsules
if the carton contains a blister strip that is labelled as Ramipril 10 mg capsules, do not take the medicine, contact your pharmacy
Advice for patients
Some cartons of Ramipril 2.5mg Capsules, manufactured by Crescent Pharma Limited, may contain blister strips of Ramipril 10 mg Capsules and are being recalled at the pharmacy level as a precautionary measure.
If you were prescribed Ramipril 2.5 mg Capsules, and received a Crescent pack with batch number GR155023, please check the blister strips inside (the batch number and expiry date information can be found on outer carton, see the images in Annex 1).
if the carton contains blister strips that are labelled as Ramipril 2.5 mg Capsules, you do not need to take further action and may continue to take the capsules
if the carton contains a blister strip that is labelled as Ramipril 10 mg capsules, do not take the medicine, contact your pharmacy
if you are unsure or have any questions, please seek advice from your pharmacy or other healthcare professionals responsible for your care
if you believe you have taken the Ramipril 10 mg Capsules and are currently experiencing any side effects such as feeling lightheaded, fainting being fatigued, then please seek immediate medical advice (Please take the leaflet that came with your medicine and any remaining capsules with you to your pharmacy or GP practice)
Both strengths are used to treat high blood pressure, heart failure and kidney disease. Any possible impact of taking a higher dose of ramipril should be assessed by your healthcare professional to determine whether any examination or tests are needed.
For reference the description of the products from the Patient Information Leaflets (PILs) are as follows:
Ramipril 2.5 mg Capsules: Capsules are light grey and light green capsules, marked with “R” on the cap and “2.5” on the body.
Ramipril 10 mg Capsules: Capsules are light grey and dark green capsules, marked with “R” on the cap and “10” on the body.
Images showing the different medicines and where to find the batch number of the product and the identification of the incorrect blister strip are included in Annex 1.
Patients who experience adverse reactions or have any questions about the medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.
Open the MHRA notice
Questions
Why has Ramipril 2.5 mg Capsules been recalled?
A fault with the packaging or delivery device of Ramipril 2.5 mg Capsules has been found. A faulty cap, seal, syringe or inhaler can mean a missed or wrong dose, or contamination of the product.
How do I know if my medicine is affected?
Compare the batch code, product licence, expiry and date code on your pack with the details listed under “Check your product” on this page. Only items that match are covered by the notice.
What should I do now?
Keep taking your medicine unless a healthcare professional tells you otherwise. Check the batch number and expiry date on your pack against the list on this page.
Do I need a new prescription?
If your pack is affected, your pharmacy can usually exchange it for an unaffected batch or another suitable product. Prescription medicines are replaced through your pharmacy or prescriber; you do not need to buy a new supply yourself. Many recalls are made at pharmacy or wholesaler level and do not require patients to act. The notice says which level applies.